Free Trial
OTCMKTS:VDRM

ViaDerma (VDRM) Stock Price, News & Analysis

ViaDerma logo
$0.0007 0.00 (0.00%)
As of 05/27/2025

About ViaDerma Stock (OTCMKTS:VDRM)

Key Stats

Today's Range
$0.0007
$0.0007
50-Day Range
$0.00
$0.02
52-Week Range
$0.00
$0.02
Volume
N/A
Average Volume
1.82 million shs
Market Capitalization
N/A
P/E Ratio
0.00
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

ViaDerma, Inc. operates as a specialty pharmaceutical company in the United States. It focuses on developing and marketing pharmaceutical products, as well as licensing its technology to companies in the pharmaceutical industry in various therapeutic areas. The company's lead product is Vitastem, a tetracycline-based topical antibiotic used for cuts, scrapes, wounds, infections, burns, acne, psoriasis, eczema, and minor injuries. It is also developing products in various fields of use, including topical antibiotics, toenail antifungal drugs, diabetic amputations, global acne, psoriasis, and eczema, as well as burns, anti-aging/wrinkle remover creams, medical cannabis, male-pattern baldness, skin cancer, erectile dysfunction, and pain management. The company was formerly known as Décor Products International, Inc. and changed its name to ViaDerma, Inc. in May 2014. ViaDerma, Inc. was incorporated in 2007 and is headquartered in Marina Del Rey, California.

Receive VDRM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ViaDerma and its competitors with MarketBeat's FREE daily newsletter.

VDRM Stock News Headlines

Is President Trump Lying To You With This?
President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to protect your 401(k), IRA, or pension from market chaos and currency collapse? The 2025 Wealth Protection Guide reveals a legal IRS strategy that may let you keep more of your retirement—regardless of what happens next. Trump’s warning was real. So is this opportunity.
See More Headlines

VDRM Stock Analysis - Frequently Asked Questions

ViaDerma's stock was trading at $0.0074 at the beginning of 2025. Since then, VDRM stock has decreased by 90.5% and is now trading at $0.0007.
View the best growth stocks for 2025 here
.

Shares of VDRM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that ViaDerma investors own include Tesla (TSLA), Dominari (DOMH), Co-Diagnostics (CODX), CEA Industries (CEAD), Organicell Regenerative Medicine (BPSR), AutoZone (AZO).

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
Pharmaceutical Products
Current Symbol
OTCMKTS:VDRM
CIK
N/A
Fax
N/A
Employees
75
Year Founded
N/A

Profitability

Trailing P/E Ratio
0.00
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

This page (OTCMKTS:VDRM) was last updated on 5/29/2025 by MarketBeat.com Staff
From Our Partners